News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Iframe sync Post navigation Previous: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Healthcare News Pharmaceutical CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 Staff January 12, 2026 Healthcare News TempraMed Closes C$2.5 Million Fully Subscribed Private Placement Staff January 12, 2026 Mental Health News TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time Staff January 12, 2026
